From NHS staff shortages to export woes, the effects of the 2016 vote are still being felt.

There are still unresolved issues with the Northern Ireland Protocol despite changes made by the EU, says a major pharmaceutical firm.

‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck.

Patients put at risk as crisis hits supplies of vital antibiotics, HRT and anti-depressants. / Vital antibiotics, hormone replacement therapy (HRT) and attention deficit hyperactivity disorder (ADHD) drugs are among those in desperately short supply this winter – with the NHS forced to pay over the odds to get drugs into Britain.

A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are being fuelled by Brexit.

In an exclusive interview with the Record, Dr Arianna Andreangeli tells how the NHS has further deteriorated since Brexit. / Scotland is facing a crisis in its National Health Service due to Covid and Tory austerity - but Brexit has caused further deadly delays in our hospitals.

EU moves to guarantee supply of medicines to Northern Ireland have so far worked but there are looming issues, peers have heard.

Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’. / “Europe is securing access to key drugs and vaccines as a single region, with huge influence and buying power. As a result of Brexit the UK is now isolated from this system, so our drug supplies could be at risk in the future,” said Dr Andrew Hill, an expert on the pharmaceutical trade.

British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.